CCI
BHVN

Columbus Circle Investors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Columbus Circle Investors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$35M Sell
407,813
-193,058
-32% -$16.4M 1.53% 17
2020
Q3 		$39.1M Buy
600,871
+98,642
+20% +$6.46M 1.7% 9
2020
Q2 		$36.7M Buy
+502,229
New +$26.7M 1.48% 17
2020
Q1 		– Sell
-23,593
Closed -$1.28M – 177
2019
Q4 		$1.28M Buy
23,593
+3,235
+16% +$160K 0.06% 138
2019
Q3 		$849K Buy
+20,358
New +$860K 0.03% 143

Other funds holding BHVN

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Columbus Circle Investors's BHVN Position: Q4 2020 in Review

Columbus Circle Investors reduced its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stake by 32% in Q4 2020, selling an estimated $16.4M and leaving 407,813 shares worth $35M. The position accounts for 1.53% of the portfolio, ranked #17.

Columbus Circle Investors first reported a position in BHVN in Q3 2019 and has held it in 5 quarters since. The position peaked at $39.1M in Q3 2020. 238 funds tracked by Wall St. Rank hold BHVN as of Q4 2020.

  • Columbus Circle Investors held 407,813 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $35M as of Q4 2020.
  • Columbus Circle Investors sold 193,058 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2020, an estimated $16.4M.
  • Biohaven Pharmaceutical Holding Company Ltd. made up 1.53% of Columbus Circle Investors's portfolio in Q4 2020, its #17 holding.
  • Columbus Circle Investors first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019 and has held it in 5 quarters since.
  • Columbus Circle Investors's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $39.1M in Q3 2020.
  • 238 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2020.

Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.